Wednesday 6/24 Insider Buying Report: VOLT, GOSS (Nasdaq.com)
On Monday, Volt Information Sciences’ Director, William J. Grubbs, made a $30,000 purchase of VOLT, buying 20,000 shares at a cost of $1.50 each. Bargain hunters are able to pick up VOLT even cheaper than Grubbs did, with the stock trading as low as $1.25 in trading on Wednesday — that’s 16.7% under Grubbs’s purchase price. Volt Information Sciences is trading off about 8.7% on the day Wednesday. Before this latest buy, Grubbs purchased VOLT at 5 other times during the past year, for a total investment of $76,401 at an average of $1.91 per share. And on Tuesday, Chief Financial Officer Bryan Giraudo purchased $25,922 worth of Gossamer Bio, purchasing 2,000 shares at a cost of $12.96 a piece. Before this latest buy, Giraudo made one other buy in the past twelve months, purchasing $18,810 shares at a cost of $16.78 each. Gossamer Bio is trading off about 2.2% on the day Wednesday.
Natera Inc (NTRA) CEO Steven Leonard Chapman Sold $1.9 million of Shares (Guru Focus)
CEO of Natera Inc., Steven Leonard Chapman, sold 41,025 shares of NTRA on 06/23/2020 at an average price of $45.1 a share. The total sale was $1.9 million. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
The Senior Vice-President of Operations of Kinross Gold (NYSE: KGC) is Selling Shares (Analyst Ratings)
Today, the Senior Vice-President of Operations of Kinross Gold (KGC), Claude J S Schimper, sold shares of KGC for $344K. Following Claude J S Schimper’s last KGC Sell transaction on February 25, 2020, the stock climbed by 1.1%. Based on Kinross Gold’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $880 million and quarterly net profit of $123 million.
Insider Sells Concert Pharmaceuticals’ Shares (Benzinga)
Shares of Concert Pharmaceuticals Inc (NASDAQ:CNCE) fell by 1.8% from the previous closing price. Stuart Nancy filed a Form 4 with the SEC on Wednesday, June 24. The insider sold 10,295 shares at an average price of $11.34. After the transaction, the executive’s stake in Concert Pharmaceuticals Inc. moved to 157,629 shares.
SEC Awards $125,000 to Whistleblower (HedgeCo.net)
(HedgeCo.Net) The Securities and Exchange Commission has announced an award of about $125,000 to a whistleblower whose information and assistance helped both the SEC and another agency bring successful actions against the perpetrator of a fraudulent securities offering. “The whistleblower’s tip helped stop a fraudulent scheme that preyed on a vulnerable investor community,” said Jane Norberg, Chief of the SEC’s Office of the Whistleblower. “Whistleblowers like the individual receiving the award today provide a valuable public service, and we encourage others to come forward with information regarding possible securities laws violations.”
